(Q54346672)

28 May 2018

title

Protective effects of IL-4 on Bacillus Calmette-Guerin and lipopolysaccharide induced immunological liver injury in mice. (English)

1 reference

28 May 2018

0 references

Nan N Zhang

1

1 reference

28 May 2018

Nong Y Huang

2

1 reference

28 May 2018

Xi K Zhou

3

1 reference

28 May 2018

Xiao L Luo

4

1 reference

28 May 2018

Chang Y Liu

5

1 reference

28 May 2018

Yan Zhang

6

1 reference

28 May 2018

Ji Qiu

7

1 reference

28 May 2018

Yin B Zhang

8

1 reference

28 May 2018

Xiu Teng

9

1 reference

28 May 2018

Can Luo

10

1 reference

28 May 2018

Xian C Chen

11

1 reference

28 May 2018

Bing Kan

12

1 reference

28 May 2018

Yong Q Mao

13

1 reference

28 May 2018

Ai P Tong

14

1 reference

28 May 2018

Yu Q Wei

15

1 reference

28 May 2018

Jiong Li

16

1 reference

28 May 2018

publication date

24 September 2011

1 reference

28 May 2018

published in

Inflammation Research

1 reference

28 May 2018

volume

61

1 reference

28 May 2018

issue

1

1 reference

28 May 2018

page(s)

17-26

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/s00011-011-0383-9

exact match

0 references

cites work

Protective effect of paeoniflorin on immunological liver injury induced by bacillus Calmette-Guerin plus lipopolysaccharide: modulation of tumour necrosis factor-alpha and interleukin-6 MRNA.

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Mycophenolate mofetil prevents lethal acute liver failure in mice induced by bacille Calmette-Guérin and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Melatonin-selenium nanoparticles inhibit oxidative stress and protect against hepatic injury induced by Bacillus Calmette-Guérin/lipopolysaccharide in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Differential effects of pyrrolidine dithiocarbamate on TNF-alpha-mediated liver injury in two different models of fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Protective effect of extract from Paeonia lactiflora and Astragalus membranaceus against liver injury induced by bacillus Calmette-Guérin and lipopolysaccharide in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Interleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections – a phase I dose toxicity trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Anti-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Effect and mechanisms of FR167653, a dual inhibitor of TNF-alpha and IL-1, on BCG plus LPS induced-liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

IL-4 Down-Regulates Lipopolysaccharide-Induced Formyl Peptide Receptor 2 in Murine Microglial Cells by Inhibiting the Activation of Mitogen-Activated Protein Kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane x receptor and its target gene CYP3a in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Overexpression of Interleukin-15 increases susceptibility to lipopolysaccharide-induced liver injury in mice primed with Mycobacterium bovis bacillus Calmette-Guerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Protection of a polysaccharide from Salvia miltiorrhiza, a Chinese medicinal herb, against immunological liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Nitric oxide synthases: which, where, how, and why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

IKKi/IKKϵ Plays a Key Role in Integrating Signals Induced by Pro-inflammatory Stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Therapeutic potential and strategies for inhibiting tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Short-term ethanol exposure increases the expression of Kupffer cell CD14 receptor and lipopolysaccharide binding protein in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0383-9

Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-gamma-deficient mice by a concomitant reduction of TNF-alpha, IL-12, and IL-18 production.

21 January 2018

1 reference

12 December 2020

Prevention of hepatic injury by a traditional Chinese formulation, BJ-JN, in mice treated with Bacille-Calmette-Guérin and lipopolysaccharide

1 reference

12 December 2020

Soluble TNF, but not membrane TNF, is critical in LPS-induced hepatitis

1 reference

12 December 2020

An antioxidant phytotherapy to rescue neuronal oxidative stress

1 reference

12 December 2020

Upregulation of TNF-alpha and IL-6 mRNA in mouse liver induced by bacille Calmette-Guerin plus lipopolysaccharide

1 reference

12 December 2020

Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infection

1 reference

12 December 2020

Reduced hepatic ischemia/reperfusion injury by IL-4: potential anti-inflammatory role of STAT6

1 reference

12 December 2020

Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus

1 reference

12 December 2020

Recombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model

1 reference

12 December 2020

Interleukin 4 therapy for patients with chronic lymphocytic leukaemia: a phase I/II study

1 reference

12 December 2020

T-cell–mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection

1 reference

12 December 2020

NF-kappaB and its regulation on the immune system.

1 reference

12 December 2020

Antiinflammatory properties of mycophenolate mofetil in murine endotoxemia: inhibition of TNF-alpha and upregulation of IL-10 release

1 reference

12 December 2020

Targeting interleukin-4 receptors for effective pancreatic cancer therapy

1 reference

12 December 2020

Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with bacille Calmette-Guerin and lipopolysaccharide

1 reference

12 December 2020

[Nf-kB transcription factor: role in the pathogenesis of inflammatory, autoimmune, and neoplastic diseases and therapy implications]

1 reference

12 December 2020

Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins

1 reference

12 December 2020

Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice

1 reference

12 December 2020

Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study

1 reference

12 December 2020

C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy

1 reference

12 December 2020

10.1007/S00011-011-0383-9

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018